Texas Oncology-Presbyterian Cancer Center

Dallas, Texas 75231

2 studies enrolling now · 2 studies all time

What they study most

Acute Myeloid Leukemia (AML), Breast Cancer

Studies at this site

• Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML — Recruiting now
• Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study — Enrolling by invitation